Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Clin Gastroenterol Hepatol. 2015 Sep;13(9):1670-5. doi: 10.1016/j.cgh.2015.03.019. Epub 2015 Mar 26.
BACKGROUND & AIMS: Reducing or eliminating falls is a focus of patient safety programs as well as health policy. Falls are tied to hospital reimbursement. However, little is known about the risk of falls among hospitalized patients with cirrhosis or factors that affect risk of falling.
We conducted a retrospective cohort study of inpatients with cirrhosis from 2010 to 2013 at a liver transplant center. Our primary aim was to determine the clinical factors associated with falls and fall-related injuries for patients with cirrhosis. Our secondary aim was to describe the rate ratio of falls and fall-related injuries among patients with cirrhosis compared with general medical inpatients.
During the study period, there were 1749 admissions to the liver service; 55 (3.1%) resulted in falls. Patients who fell were more likely to have received benzodiazepines (50.9% vs 16.7%, P < .0001) and antipsychotic agents (30.9% vs 7.3%, P < .0001). After adjusting for hepatic encephalopathy, the respective odds of a fall after benzodiazepine or antipsychotic exposure were 6.59 (95% confidence interval [CI], 3.76-11.59) and 3.72 (95% CI, 1.90-7.06). The adjusted risk of a fall-related injury was also significantly associated with benzodiazepine and antipsychotic agents, with respective odds ratios of 3.45 (95% CI, 1.39-8.23) and 3.42 (95% CI, 1.09-8.99). Fall-related injuries occurred at a rate of 1.70/1000 patient-days for patients with cirrhosis vs 0.5/1000 patient-days for patients in the general medical service. Accordingly, the rate ratio for a fall-related injury among patients with cirrhosis was 3.37 (95% CI, 1.99-5.72; P < .0001).
Psychoactive medications are associated with an increased adjusted risk of falls and fall-related injuries in hospitalized patients with cirrhosis.
降低或消除跌倒事件是患者安全计划和卫生政策的重点。跌倒与医院报销挂钩。然而,对于肝硬化住院患者的跌倒风险以及影响跌倒风险的因素知之甚少。
我们对 2010 年至 2013 年在肝脏移植中心住院的肝硬化患者进行了回顾性队列研究。我们的主要目的是确定与肝硬化患者跌倒和与跌倒相关伤害相关的临床因素。我们的次要目的是描述与一般内科住院患者相比,肝硬化患者的跌倒和与跌倒相关伤害的发生率比。
在研究期间,肝脏科有 1749 例住院患者;其中 55 例(3.1%)发生跌倒。跌倒患者更有可能接受苯二氮䓬类药物(50.9%比 16.7%,P<.0001)和抗精神病药物(30.9%比 7.3%,P<.0001)。在调整肝性脑病后,苯二氮䓬类或抗精神病药物暴露后跌倒的比值比分别为 6.59(95%置信区间[CI],3.76-11.59)和 3.72(95%CI,1.90-7.06)。与跌倒相关伤害的调整风险也与苯二氮䓬类和抗精神病药物显著相关,相应的比值比分别为 3.45(95%CI,1.39-8.23)和 3.42(95%CI,1.09-8.99)。肝硬化患者的跌倒相关伤害发生率为 1.70/1000 患者天,而一般内科患者的发生率为 0.5/1000 患者天。因此,肝硬化患者跌倒相关伤害的发生率比为 3.37(95%CI,1.99-5.72;P<.0001)。
在肝硬化住院患者中,精神活性药物与跌倒和跌倒相关伤害的调整后风险增加相关。